Do we need prognostic factors in nodal-negative breast cancer?: Arbiter:
Open Access
- 29 February 2000
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (3) , 302-306
- https://doi.org/10.1016/s0959-8049(99)00303-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Role of immunohistochemical detection of lymph-node metastases in management of breast cancerThe Lancet, 1999
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?Breast Cancer Research and Treatment, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.Journal of Clinical Oncology, 1998
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor MarkersJNCI Journal of the National Cancer Institute, 1996
- Statistical aspects of prognostic factor studies in oncologyBritish Journal of Cancer, 1994
- Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991